Longitudinal analysis of serum microRNAs as predictors of cirrhosis regression during treatment of hepatitis B virus infection.
Cody OrrRob MyersBiao LiZhaoshi JiangJohn FlahertyAnuj GaggarEric G MeissnerPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
In cirrhotic patients with chronic HBV infection treated with antiviral therapy, serum miRNAs have differential expression based on fibrosis regression, suggesting potential utility as biomarkers.